.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Federal Trade Commission
QuintilesIMS
US Army
Deloitte
Mallinckrodt
US Department of Justice
Johnson and Johnson
Moodys
Dow

Generated: July 27, 2017

DrugPatentWatch Database Preview

ESOMEPRAZOLE MAGNESIUM Drug Profile

« Back to Dashboard

Which patents cover Esomeprazole Magnesium, and what generic Esomeprazole Magnesium alternatives are available?

Esomeprazole Magnesium is a drug marketed by Ivax Sub Teva Pharms, Aurobindo Pharma Ltd, Mylan Pharms Inc, Torrent Pharms Ltd, Dr Reddys Labs Ltd, and Hetero Labs Ltd Iii. and is included in six NDAs.

The generic ingredient in ESOMEPRAZOLE MAGNESIUM is esomeprazole magnesium. There are sixty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the esomeprazole magnesium profile page.

Summary for Tradename: ESOMEPRAZOLE MAGNESIUM

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list17
Bulk Api Vendors: see list63
Clinical Trials: see list655
Patent Applications: see list17
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ESOMEPRAZOLE MAGNESIUM at DailyMed

Pharmacology for Tradename: ESOMEPRAZOLE MAGNESIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium
CAPSULE, DELAYED REL PELLETS;ORAL078003-001Jan 26, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms Ltd
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium
CAPSULE, DELAYED REL PELLETS;ORAL203636-001Oct 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium
CAPSULE, DELAYED REL PELLETS;ORAL205606-002Apr 21, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd Iii
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium
CAPSULE, DELAYED REL PELLETS;ORAL202784-002Sep 21, 2015BXRXNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms Ltd
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium
CAPSULE, DELAYED REL PELLETS;ORAL203636-002Oct 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Merck
Deloitte
Colorcon
Argus Health
Cipla
Healthtrust
Chinese Patent Office
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot